Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Cardioprotection in STEMI (EMPIRE)
NCT01580514Phase 4Completed
- Sponsor
- Kyung Hee University Medical Center
- Start
- Sep 2009
- Primary completion
- Aug 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in ST-segment elevation myocardial infarction (STEMI), sponsored by Kyung Hee University Medical Center. Started Sep 2009; status: completed.
02
Drugs
exenatide
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01580514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580514.